Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria.
Mejstrikova E, Volejnikova J, Fronkova E, Zdrahalova K, Kalina T, Sterba J, Jabali Y, Mihal V, Blazek B, Cerna Z, Prochazkova D, Hak J, Zemanova Z, Jarosova M, Oltova A, Sedlacek P, Schwarz J, Zuna J, Trka J, Stary J, Hrusak O. Mejstrikova E, et al. Among authors: jabali y. Haematologica. 2010 Jun;95(6):928-35. doi: 10.3324/haematol.2009.014506. Epub 2010 Feb 9. Haematologica. 2010. PMID: 20145275 Free PMC article.
Minimal residual disease in peripheral blood at day 15 identifies a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with superior prognosis.
Volejnikova J, Mejstrikova E, Valova T, Reznickova L, Hodonska L, Mihal V, Sterba J, Jabali Y, Prochazkova D, Blazek B, Hak J, Cerna Z, Hrusak O, Stary J, Trka J, Fronkova E. Volejnikova J, et al. Among authors: jabali y. Haematologica. 2011 Dec;96(12):1815-21. doi: 10.3324/haematol.2011.042937. Epub 2011 Aug 31. Haematologica. 2011. PMID: 21880630 Free PMC article. Clinical Trial.
[Improved results in children with acute lymphoblastic leukemia treated with the ALL-BFM 90 protocol in the Czech Republic].
Starý J, Gajdos P, Blazek B, Ptoszková H, Mihál V, Pospísilová D, Hrstková H, Dembická D, Kopecná L, Slavík Z, Hak J, Procházková D, Zahálka F, Cerná Z, Jabali Y, Timr P, Vávra V, Mydlil J, Hrusák O, Trka J. Starý J, et al. Among authors: jabali y. Cas Lek Cesk. 2003;142(7):404-9. Cas Lek Cesk. 2003. PMID: 14515443 Clinical Trial. Czech.
Long-term results of treatment of childhood acute lymphoblastic leukemia in the Czech Republic.
Stary J, Jabali Y, Trka J, Hrusak O, Gajdos P, Hrstkova H, Sterba J, Blazek B, Hak J, Prochazkova D, Cerna Z, Smisek P, Sedlacek P, Vavra V, Mihal V, Hrodek O; Czech Pediatric Hematology working group. Stary J, et al. Among authors: jabali y. Leukemia. 2010 Feb;24(2):425-8. doi: 10.1038/leu.2009.255. Epub 2009 Dec 17. Leukemia. 2010. PMID: 20016535 Clinical Trial. No abstract available.
[The prospects for children with acute lymphoblastic leukemia of being cured has increased in the Czech Republic in the 21st century to 90% - outcome of the ALL-IC BFM 2002 trial].
Zdráhalová K, Štěrba J, Domanský J, Blažek B, Ptoszková H, Mihál V, Novák Z, Hak J, Procházková D, Černá Z, Timr P, Jabali Y, Sedláček P, Smíšek P, Zemanová Z, Jarošová M, Houdková A, Mejstříková E, Hrušák O, Zuna J, Janotová I, Trka J, Starý J. Zdráhalová K, et al. Among authors: jabali y. Cas Lek Cesk. 2015;154(2):79-89. Cas Lek Cesk. 2015. PMID: 25994910 Clinical Trial. Czech.
Blast clearance after one week of corticosteroids correlates with outcome and genetics but does not justify adding a residual disease time point in acute lymphoblastic leukemia treatment.
Vakrmanova B, Fronkova E, Zuna J, Janotova I, Jabali Y, Rezkova Reznickova L, Zdrahalova K, Trka J, Stary J, Hrusak O, Mejstrikova E. Vakrmanova B, et al. Among authors: jabali y. Leuk Lymphoma. 2021 Mar;62(3):752-754. doi: 10.1080/10428194.2020.1839659. Epub 2020 Oct 29. Leuk Lymphoma. 2021. PMID: 33118409 No abstract available.
16 results